Mayer Brown advises Marlin Equity Partners on Majority Growth Investment in Radar Healthcare
Marlin Equity Partners (“Marlin”) on its majority growth investment in Radar Healthcare, a provider of risk, quality and compliance software for the healthcare and social care sectors.
The partnership will support Radar Healthcare’s strategic goals of advancing product development and accelerating its international expansion.
Radar Healthcare’s suite of solutions caters to over 250 healthcare and social care participants worldwide, with the goal of ensuring the safety of patients and residents while delivering excellent care outcomes. It empowers health and social care organisations to make a meaningful impact on patient safety and quality of care. By blending digital innovation with real-world healthcare expertise, it enables providers to not only meet regulatory standards but to actively spot trends, prevent incidents, and drive continuous improvement.
Marlin is a global investment firm with approximately $9 billion in capital commitments. It is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Since its inception, Marlin, through its group of funds and related companies, has successfully completed nearly 250 acquisitions.
The Mayer Brown team was led by Private Equity partners James West and Electra Callan and included Tax partner James Hill, Employment & Benefits partner Christopher Fisher, counsel James Perrott and consultant Andrew Stanger, IP partner Mark Prinsley, Antitrust & Competition counsel Mark Hills, Regulatory partner Musonda Kapotwe (all London) and Corporate & Securities counsel George Rudy (New York).
